Initial Management of Seizure in Adults
NEJM 385:251-263, Smith, P.E.M., 2021
Neurological Autoantibody Prevalence in Epilepsy on Unknown Etiology
JAMA Neurol 74:397-402,384, Dubey, D.,et al, 2017
Epilepsy: New Advances
Lancet 385:884-898, Moshe, S.L.,et al, 2015
Drug-Resistant Epilepsy
NEJM 365:919-26, Kwan, P.,et al, 2011
Generic Antiepileptic Drugs and Associated Medical Resource Utilization in the United States
Neurol 74:1566-1574, 1562, Labiner,D.M., et al, 2010
A Systematic Review of Antiepilpetic Drug Initiation and Withdrawal
The Neurologist 15:122-131, Shih,J.J &Ochoa,J.G., 2009
Seizure Relapse and Development of Drug Resistance Following Long-Term Seizure Remission
Arch Neurol 66:1233-1239, Schiller,Y., 2009
Recurrence of Afebrile Status Epilepticus in a Population-Based Study in Rochester, Minnesota
Neurol 69:73-78, Hesdorffer,D.C.,et al, 2007
Neonatal Seizures
Ann Neurol 62:112-120, Silverstein,F.S. &Jensen,F.E., 2007
Risk Factors for Sudden Unexpected Death in epilepsy:A Case-Control Study
Lancet 353:888-893, Nilsson,L.,et al, 1999
The SANAD II Study of the Effectiveness and Cost-Effectiveness of Valproate Versus Levetiracetam for Newly Diagnosed Generalised and Unclassifiable Epilepsy: An Open-Label, Non-Inferiority, Multicentre, Phase 4, Randomised Controlled Trial
Lancet 397:1375-1386, Marson, A.,et al, 2021
The Outcome of Therapies in Refractory and Super-Refractory Convulsive Status Epilepticus and Recommendations for Therapy
BRAIN 135:2314-2328, Shorvon, S. & Ferlisi, M., 2012
Initial Management of Epilepsy
NEJM 359:166-176, French,J.A. &Pedley,T.A., 2008
Nonadherence to Antiepileptic Drugs and Increased Mortality: Findings from the RANsom Study
Neurol 71:1572-1578, Faught,E.,et al, 2008
The SANAD Study of Effectiveness of Valproate,Lamotrigine,or Topiramate for Generalised and Unclassifiable Epilepsy:An Unblinded Randomised Controlled Trial
Lancet 369:1016-1026, Marson,A.G.,et al, 2007
Seizure Control and Treatment in Pregnancy, Observations from the EURAP Epilepsy Pregnancy Registry
Neurol 66:354-360, The EURAP Study Group, 2006